Antidepressant Safety Concerns Depress Zoloft; Forest, Wyeth Still Happy
Executive Summary
Pfizer's Zoloft may feel the greatest negative performance impact from FDA's decision to require a class-wide black box warning for antidepressants
You may also be interested in...
Antidepressant Relabeling Will Include Pediatric Efficacy Data
FDA's plan for relabeling antidepressants to address pediatric safety concerns will involve some negotiation with sponsors over how best to present efficacy data
Antidepressant Relabeling Will Include Pediatric Efficacy Data
FDA's plan for relabeling antidepressants to address pediatric safety concerns will involve some negotiation with sponsors over how best to present efficacy data
Antidepressant “Black Box” Presents Barrier To DTC Advertising
FDA's proposed "black box" warning for all antidepressants would likely mean an end to television ads for the products